About Skinopathy AI™
The pandemic has placed an incredible burden on the healthcare system, and, unfortunately, skin cancer screenings have plummeted resulting in an alarming trend where initial late-stage skin cancer diagnoses are increasing at a rapid pace.
Skinopathy AI™ technology was created so that people who fear the threat of skin disease or skin cancer could get a preliminary analysis as to the urgency of their lesions, without the need to wait months for an appointment or risk close contact with someone with Covid-19.
Since the technology is geographically agnostic, we are also able to deploy it to under-serviced regions and provide people with unparalleled access to healthcare.